Syndromic panels for respiratory molecular assays allow for simultaneous detection of a broad range of pathogens, reducing the need for multiple, individual tests from a single patient sample. Highly sensitive molecular diagnostic methods provide superior accuracy in identifying pathogens compared to traditional culture or antigen tests and shorter turn around times aiding timely clinical decisions